Saturday, November 14, 2026

Ripple On Bullish Momentum: 4.14% Up In The Last 6 Hours

ViaNews Editorial Team

December 24, 2020

Automated market report from our archive (2020–2024), published before source-traceability. How we work

Ripple On Bullish Momentum: 4.14% Up In The Last 6 Hours

Ripple is currently on bullish momentum. At 17:03 EST on Thu 24 Dec, Ripple is at $0.27 and up by 4.14% in the last 6 hours.

Ripple Range

Over the last six hours, Ripple's higher value was $0.27 and the lower value was $0.26.

Over the last twelve hours, Ripple's higher value was $0.28 and the lower value was $0.26.

Regarding Ripple's daily highs and lows, it's 8.68% up from its trailing 24-hour low of $0.25 and 9.433% down from its trailing 24-hour high of $0.30.

In relation to Ripple's yearly highs and lows, it's 136.056% up from its 52-week low and 64.622% down from its 52-week high.

Last news about Ripple

Ripple to face SEC suit over XRP cryptocurrency. According to The Wall Street Journal on Tue Dec 22, "Ripple Inc. said it will defend itself against a lawsuit from the Securities and Exchange Commission that claims the company violated investor-protection laws when it sold a bitcoin-like digital asset called XRP.", "Ripple said it was informed by the commission on Monday that regulators soon plan to sue the company, Chief Executive Brad Garlinghouse and co-founder Chris Larsen in federal civil court. "

Cryptocurrency firm ripple expects to be sued by the sec; XRP plunges. According to CNBC on Tue Dec 22, "According to Ripple, the SEC plans to argue XRP is a security and that Ripple violated U.S. laws by not registering the token with the SEC before listing it.", "The fresh scrutiny over Ripple comes days after the Treasury Department proposed a new bitcoin disclosure rule aimed at closing money-laundering regulatory gaps. "

Ripple says it faces SEC lawsuit as cryptocurrency XRP drops. According to Bloomberg Quint on Tue Dec 22, "Ripple will challenge the suit in the courts "to get clear rules of the road for the entire industry in the U.S.," he added.", "XRP, the world's third-largest cryptocurrency, slumped after Ripple Labs Inc. said it faces a U.S. Securities and Exchange Commission lawsuit over its affiliated token."

Ripple labs, executives sued by SEC for failing to register XRP. According to Bloomberg Quint on Tue Dec 22, ""Ripple used this money to fund its operations without disclosing how it was doing so, or the full extent of its payments to others to assist in its efforts to develop a 'use' for XRP and maintain XRP secondary trading markets."", "Ripple Labs Inc. and its top executives were accused by the U.S. Securities and Exchange Commission of misleading investors in XRP, the world's third-largest cryptocurrency, by selling more than $1 billion of the virtual tokens without registering with the agency."

US regulator charges ripple over its XRP asset, saying it's a $1.3 billion unregistered offering, not a cryptocurrency. According to Business Insider on Wed Dec 23, "Ripple violated federal securities laws by not registering XRP as a security, which would require greater disclosure, giving investors a more complete background as they value it, the SEC said.", ""To be clear, this is all based on their illogical claim that XRP is, in their view, somehow the functional equivalent of a share of stock," Garlinghouse wrote on Ripple's company blog."

High-flying crypto fund dumps XRP with ripple in SEC ‘hot water’. According to Bloomberg Quint on Wed Dec 23, "Not only is Ripple in "hot water" and unlikely to beat the SEC's lawsuit, but XRP may become more difficult to trade and transact in should U.S. marketplaces be unwilling to list it, according to a Bloomberg Intelligence report.", "San Fransisco-based Ripple has denied the allegations. "

News about Bitcoin

Elon Musk inquired on twitter about 'large' Bitcoin transactions after a crypto booster suggested he convert Tesla's balance sheet. According to Business Insider on Mon Dec 21, "Before the exchange with Saylor, he tweeted "Bitcoin is my safe word," but then followed up by saying, "Just kidding, who needs a safe word anyway!?"", "Following the Saylor conversation, Musk tweeted: "Bitcoin is almost as bs as fiat money," and then suggested to his followers he's a fan of Dogecoin, a parody cryptocurrency."

 michael saylor, the CEO who turned a software company into a Bitcoin company. According to Bloomberg Quint on Thu Dec 24, "This past summer, the business intelligence software company MicroStrategy made waves when it put some of its extra cash into Bitcoin. ", "We speak with MicroStrategy's CEO, Michael Saylor, on why he thinks Bitcoin is the best reserve asset for any company."

Bitcoin rally has already outlasted 2017 run. According to The Wall Street Journal on Thu Dec 24, "Bitcoin bulls say the money fueling this year's rally is coming from more reliable sources than past rallies. "

Bitcoin crushes doubters as 224% rally proves it’s here to stay. According to Bloomberg Quint on Thu Dec 24, "Talking Gold and Bitcoin with Anthony "Pomp" Pompliano", "Bitcoin just won't go away. "

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com